Infant feeding and adult glucose tolerance, lipid profile, blood pressure, and obesity

A C Ravelli, J H van der Meulen, C Osmond, D J Barker, O P Bleker, A C Ravelli, J H van der Meulen, C Osmond, D J Barker, O P Bleker

Abstract

Background: It is generally accepted that breast feeding has a beneficial effect on the health of infants and young children. Recently, a few studies have shown that the method of infant feeding is also associated with cardiovascular disease and its risk factors in adult life.

Aims: To examine the association between the method of infant feeding in the first weeks after birth and glucose tolerance, plasma lipid profile, blood pressure, and body mass in adults aged 48-53 years.

Methods: Subjects born at term between 1 November 1943 and 28 February 1947 in the Wilhelmina Gasthuis in Amsterdam around the time of a severe period of famine (late November 1944 to early May 1945). For 625 subjects, information was available about infant feeding at the time of discharge from hospital (on average 10.4 days after birth), and at least one blood sample after an overnight fast.

Results: Subjects who were bottle fed had a higher mean 120 minute plasma glucose concentration after a standard oral glucose tolerance test than those who were exclusively breast fed. They also had a higher plasma low density lipoprotein (LDL) cholesterol concentration, a lower high density lipoprotein (HDL) cholesterol concentration, and a higher LDL/HDL ratio. Systolic blood pressure and body mass index were not affected by the method of infant feeding.

Conclusions: Exclusive breast feeding seems to have a protective effect against some risk factors for cardiovascular disease in later life.

References

    1. Am J Clin Nutr. 1999 Nov;70(5):811-6
    1. BMJ. 1992 Mar 28;304(6830):801-5
    1. Lancet. 1979 Jul 14;2(8133):57-8
    1. Lancet. 1980 Jun 14;1(8181):1267-9
    1. J Epidemiol Community Health. 1980 Sep;34(3):164-7
    1. J Pediatr. 1981 Jun;98(6):883-7
    1. Acta Paediatr. 1993 Apr;82(4):377-82
    1. Acta Paediatr. 1993 Aug;82(8):699-704
    1. BMJ. 1994 Jul 30;309(6950):304-8
    1. Diabetologia. 1994 Sep;37 Suppl 2:S162-8
    1. BMJ. 1995 Feb 18;310(6977):428-32
    1. Diabet Med. 1995 Oct;12(10):931
    1. Ann Intern Med. 1996 Jan 1;124(1 Pt 2):110-6
    1. Nutr Rev. 1996 Feb;54(2 Pt 2):S31-40
    1. Pediatr Res. 1996 Oct;40(4):627-32
    1. Br J Gen Pract. 1996 Oct;46(411):613-7
    1. BMJ. 1996 Dec 7;313(7070):1434-8
    1. Br Med Bull. 1997 Jan;53(1):123-34
    1. Lancet. 1997 Jul 19;350(9072):166-8
    1. Early Hum Dev. 1997 Oct 29;49 Suppl:S131-42
    1. J Clin Endocrinol Metab. 1997 Dec;82(12):4270-3
    1. Obes Res. 1997 Nov;5(6):538-41
    1. Lancet. 1998 Jan 17;351(9097):173-7
    1. BMJ. 1998 Jan 3;316(7124):21-5
    1. J Nutr. 1998 Feb;128(2 Suppl):401S-406S
    1. J Clin Endocrinol Metab. 1998 May;83(5):1810-3
    1. Physiol Res. 1997;46(1):21-5
    1. J Hypertens. 1999 Mar;17(3):325-30
    1. BMJ. 1999 Jul 17;319(7203):147-50
    1. J Epidemiol Community Health. 1984 Sep;38(3):218-25
    1. J Pediatr Gastroenterol Nutr. 1988 Jan-Feb;7(1):10-6
    1. BMJ. 1989 Sep 2;299(6699):587-91
    1. J Clin Epidemiol. 1992 May;45(5):513-8
    1. Maandschr Kindergeneeskd. 1965 Oct;33(10):341-51

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe